MAPK1 and cancer: Vx-11e, a selective inhibitor of ERK2, has been shown to promote intrinsic apoptosis in cancer cells by enhancing reactive oxygen species (ROS) production, which leads to mitochondrial dysfunction and the subsequent release of pro-apoptotic factors such as cytochrome c.